Physician profile
Elick Jan Combs
NPI 1205459377
$1,394.00
in general payments reported to CMS, 2019-2025
12 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.30 · 2021: $58.47 · 2022: $487 · 2023: $384 · 2024: $194 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $630.98 | 2022-2025 | Infuse, Ultra Multifocal Toric |
| Alcon Vision LLC | $201.37 | 2022-2023 | |
| Oyster Point Pharma, INC. | $142.00 | 2022-2024 | Tyrvaya |
| Coopervision INC. | $131.32 | 2022-2025 | Myday Contact Lens |
| Abbvie INC. | $80.92 | 2022-2025 | Durysta |
| Rxsight INC | $75.24 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Johnson & Johnson Vision Care, INC. | $45.43 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $28.03 | 2021 | |
| Allergan, INC. | $15.94 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.80 | 2022 | |
| Aerie Pharmaceuticals, INC. | $14.50 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $13.47 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elick Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.